EURO BIOT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.98 USD | +0.04% |
|
+0.04% | +7.02% |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 158.9 | 165.6 |
| Enterprise Value (EV) 1 | 158 | 165.3 |
| P/E ratio | 112 x | 590 x |
| Yield | - | - |
| Capitalization / Revenue | - | - |
| EV / Revenue | - | - |
| EV / EBITDA | - | - |
| EV / FCF | - | -112,398,927 x |
| FCF Yield | - | -0% |
| Price to Book | -23.8 x | -20.6 x |
| Nbr of stocks (in thousands) | 16,399 | 16,399 |
| Reference price 2 | 9.690 | 10.10 |
| Announcement Date | 22-03-31 | 23-02-28 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Net sales | - | - |
| EBITDA | - | - |
| EBIT 1 | -1.1 | -2.818 |
| Operating Margin | - | - |
| Earnings before Tax (EBT) 1 | 1.479 | 0.3429 |
| Net income 1 | 1.479 | 0.3429 |
| Net margin | - | - |
| EPS 2 | 0.0866 | 0.0171 |
| Free Cash Flow | - | -1.471 |
| FCF margin | - | - |
| FCF Conversion (EBITDA) | - | - |
| FCF Conversion (Net income) | - | - |
| Dividend per Share | - | - |
| Announcement Date | 22-03-31 | 23-02-28 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Net Debt 1 | - | - |
| Net Cash position 1 | 0.87 | 0.31 |
| Leverage (Debt/EBITDA) | - | - |
| Free Cash Flow | - | -1.47 |
| ROE (net income / shareholders' equity) | - | -4.65% |
| ROA (Net income/ Total Assets) | - | -1.36% |
| Assets 1 | - | -25.14 |
| Book Value Per Share 2 | -0.4100 | -0.4900 |
| Cash Flow per Share 2 | 0.0500 | 0.0200 |
| Capex | - | - |
| Capex / Sales | - | - |
| Announcement Date | 22-03-31 | 23-02-28 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- EBAC Stock
- Financials EURO BIOT
